Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Surgical Endoscopy|January 26, 2022
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: a single-center early experience propensity-matched analysisTali Shaltiel, Daniel Solomon, Eric R Pletcher, et al.The Journal of Surgical Research|April 25, 2022
Hypophosphatemia Is Associated With Postoperative Morbidity After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: A Retrospective StudyTali Shaltiel, Elizabeth M Gleeson, Eric R Pletcher, et al.Annals of Surgical Oncology|May 20, 2023
Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal AdenocarcinomaRebekah Macfie, Yael Berger, Hongdau Liu, et al.Pancreas|October 29, 2021
Adjuvant Chemotherapy Is Not Guided by Pathologic Treatment Effect After Neoadjuvant Chemotherapy in Pancreatic CancerElizabeth M Gleeson, Natasha Leigh, Benjamin J Golas, et al.World Journal of Surgery|April 4, 2023
Perineural Invasion of Pancreatic Ductal Adenocarcinoma is Associated with Early Recurrence after Neoadjuvant Therapy Followed by ResectionDa Eun Cha, Allen T Yu, Nazanin Khajoueinejad, et al.Annals of Surgical Oncology|July 13, 2024
Genetic Clustering of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Patients of Colorectal Origin: KRAS and Not TP53 Cluster Alterations are Associated with Poor OutcomesAllen T Yu, David N Hanna, Thomas M Li, et al.Cancer|February 25, 2021
Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotypeTali Shaltiel, Serena Zheng, Cleo Siderides, et al.Journal of Surgical Oncology|July 31, 2023
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Effects of postoperative fluids beyond the first 24 hYael Berger, Brianne J Sullivan, Eliahu Y Bekhor, et al.Annals of Surgical Oncology|October 14, 2025
Worse Survival in Co-Altered RAS-TP53 Patients With Resected Colorectal Liver MetastasesJudy Li, Giacomo Waller, Yunyun Qin, et al.The Journal of Surgical Research|March 4, 2023
T1 Gastric Cancer Is Associated With a High Incidence of Regional Lymph Node MetastasesSayed Imtiaz, Yael Berger, Elizabeth Gleeson, et al.Pageof 4